{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:32:52Z","timestamp":1790688772097,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"BRIDGE \u2013 Translational Excellence Programme at the Faculty of Health and Medical Sciences, University of Copenhagen","award":["NNF20SA0064340"],"award-info":[{"award-number":["NNF20SA0064340"]}]},{"DOI":"10.13039\/501100013826","name":"Candys Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lundbeck Foundation Professor Grant","award":["R310-2018\u20133711"],"award-info":[{"award-number":["R310-2018\u20133711"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Calcitonin gene-related peptide (CGRP) antagonizing drugs represents the most important advance in migraine therapy for decades. However, these new drugs are only effective in 50\u201360% of patients. Recent studies have shown that the pituitary adenylate cyclase-activating peptide (PACAP38) pathway is independent from the CGRP signaling pathway. Here, we investigate PACAP38 signaling pathways in relation to glyceryl trinitrate (GTN), levcromakalim and sumatriptan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In vivo mouse models of PACAP38-, GTN-, and levcromakalim-induced migraine were applied using tactile sensitivity to von Frey filaments as measuring readout. Signaling pathways involved in the three models were dissected using PACAP-inhibiting antibodies (mAbs) and sumatriptan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We showed that PACAP mAbs block PACAP38 induced hypersensitivity, but not via signaling pathways involved in GTN and levcromakalim. Also, sumatriptan has no effect on PACAP38-induced hypersensitivity relevant to migraine. This is the first study testing the effect of a PACAP-inhibiting drug on GTN- and levcromakalim-induced hypersensitivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Based on the findings in our mouse model of migraine using migraine-inducing compounds and anti-migraine drugs, we suggest that PACAP acts via a distinct pathway. Using PACAP38 antagonism may be a novel therapeutic target of interest in a subgroup of migraine patients who do not respond to existing therapies.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-022-01523-8","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:03:30Z","timestamp":1670249010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine"],"prefix":"10.1186","volume":"23","author":[{"given":"Song","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Ernstsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hay-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M\u00f8bjerg","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Messoud","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Louise","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"issue":"19","key":"1523_CR1","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"AM Migraine","year":"2020","unstructured":"Migraine AM (2020) Ropper AH, editor. N Engl J Med 383(19):1866\u20131876","journal-title":"N Engl J Med"},{"key":"1523_CR2","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/S0140-6736(19)32504-8","volume":"394","author":"A Charles","year":"2019","unstructured":"Charles A, Pozo-Rosich P (2019) Targeting calcitonin gene-related peptide: a new era in migraine therapy. Lancet. 394:1765\u201374 (Lancet Publishing Group)","journal-title":"Lancet."},{"issue":"4","key":"1523_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(16)00019-3","volume":"15","author":"H Sun","year":"2016","unstructured":"Sun H, Dodick DW, Silberstein S, Goadsby PJ, Reuter U, Ashina M et al (2016) Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol 15(4):382\u2013390","journal-title":"Lancet Neurol"},{"issue":"9","key":"1523_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1474-4422(14)70128-0","volume":"13","author":"DW Dodick","year":"2014","unstructured":"Dodick DW, Goadsby PJ, Spierings ELH, Scherer JC, Sweeney SP, Grayzel DS (2014) Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Neurol 13(9):885\u2013892","journal-title":"Lancet Neurol"},{"issue":"11","key":"1523_CR5","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(15)00245-8","volume":"14","author":"ME Bigal","year":"2015","unstructured":"Bigal ME, Edvinsson L, Rapoport AM, Lipton RB, Spierings ELH, Diener H-C et al (2015) Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. Lancet Neurol 14(11):1091\u20131100","journal-title":"Lancet Neurol"},{"issue":"11","key":"1523_CR6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","volume":"13","author":"DW Dodick","year":"2014","unstructured":"Dodick DW, Goadsby PJ, Silberstein SD, Lipton RB, Olesen J, Ashina M et al (2014) Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial. Lancet Neurol 13(11):1100\u20131107","journal-title":"Lancet Neurol"},{"issue":"Pt 1","key":"1523_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132(Pt 1):16\u201325","journal-title":"Brain"},{"key":"1523_CR8","unstructured":"A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments. H. Lundbeck A\/S. 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05133323"},{"key":"1523_CR9","unstructured":"A Study of LY3451838 in Participants With Migraine. Eli Lilly and Company. 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04498910"},{"issue":"7","key":"1523_CR10","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1093\/brain\/awac040","volume":"145","author":"C Ernstsen","year":"2022","unstructured":"Ernstsen C, Christensen SL, Rasmussen RH, Nielsen BS, Jansen-Olesen I, Olesen J et al (2022) The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target? Brain 145(7):2450\u20132460","journal-title":"Brain"},{"issue":"21","key":"1523_CR11","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1523\/JNEUROSCI.2200-20.2021","volume":"41","author":"A Kuburas","year":"2021","unstructured":"Kuburas A, Mason BN, Hing B, Wattiez AS, Reis AS, Sowers LP et al (2021) PACAP Induces Light Aversion in Mice by an Inheritable Mechanism Independent of CGRP. J Neurosci 41(21):4697\u20134715","journal-title":"J Neurosci"},{"issue":"14","key":"1523_CR12","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1177\/0333102419861726","volume":"39","author":"SL Christensen","year":"2019","unstructured":"Christensen SL, Petersen S, Kristensen DM, Olesen J, Munro G (2019) Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain. Cephalalgia 39(14):1827\u20131837","journal-title":"Cephalalgia"},{"issue":"3","key":"1523_CR13","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1177\/0333102417693833","volume":"38","author":"SL Christensen","year":"2018","unstructured":"Christensen SL, Petersen S, S\u00f8rensen DB, Olesen J, Jansen-Olesen I (2018) Cilostazol induces C-fos expression in the trigeminal nucleus caudalis and behavioural changes suggestive of headache with the migraine-like feature photophobia in female rats. Cephalalgia 38(3):452\u2013465","journal-title":"Cephalalgia"},{"issue":"7","key":"1523_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/0333102420925513","volume":"40","author":"SL Christensen","year":"2020","unstructured":"Christensen SL, Munro G, Petersen S, Shabir A, Jansen-Olesen I, Kristensen DM et al (2020) ATP sensitive potassium (KATP) channel inhibition: A promising new drug target for migraine. Cephalalgia 40(7):650\u2013664","journal-title":"Cephalalgia"},{"issue":"148","key":"1523_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuropharm.2018.12.017","volume":"1","author":"LS Moye","year":"2019","unstructured":"Moye LS, Tipton AF, Dripps I, Sheets Z, Crombie A, Violin JD et al (2019) Delta opioid receptor agonists are effective for multiple types of headache disorders. Neuropharmacology 1(148):77\u201386","journal-title":"Neuropharmacology"},{"issue":"1","key":"1523_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.nbd.2011.10.010","volume":"45","author":"A Markovics","year":"2012","unstructured":"Markovics A, Kormos V, Gaszner B, Lashgarara A, Szoke E, Sandor K et al (2012) Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice. Neurobiol Dis 45(1):633\u2013644","journal-title":"Neurobiol Dis"},{"key":"1523_CR17","doi-asserted-by":"crossref","unstructured":"Ernstsen C, Christensen SL, Olesen J, Kristensen DM (2021) No additive effect of combining sumatriptan and olcegepant in the GTN mouse model of migraine. Cephalalgia 41(3):329\u2013339","DOI":"10.1177\/0333102420963857"},{"key":"1523_CR18","doi-asserted-by":"crossref","unstructured":"Christensen SL, Ernstsen C, Olesen J, Kristensen DM (2020) No central action of CGRP antagonising drugs in the GTN mouse model of migraine. Cephalalgia 40(9):924\u2013934","DOI":"10.1177\/0333102420914913"},{"issue":"11","key":"1523_CR19","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1177\/0333102415623070","volume":"36","author":"AF Tipton","year":"2016","unstructured":"Tipton AF, Tarash I, McGuire B, Charles A, Pradhan AA (2016) The effects of acute and preventive migraine therapies in a mouse model of chronic migraine. Cephalalgia 36(11):1048\u20131056","journal-title":"Cephalalgia"},{"issue":"2","key":"1523_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.pain.2013.10.004","volume":"155","author":"AA Pradhan","year":"2014","unstructured":"Pradhan AA, Smith ML, McGuire B, Tarash I, Evans CJ, Charles A (2014) Characterization of a novel model of chronic migraine. Pain 155(2):269\u2013274","journal-title":"Pain"},{"issue":"2","key":"1523_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1468-2982.2009.01864.x","volume":"30","author":"EA Bates","year":"2010","unstructured":"Bates EA, Nikai T, Brennan KC, Fu YH, Charles AC, Basbaum AI et al (2010) Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice. Cephalalgia 30(2):170\u2013178","journal-title":"Cephalalgia"},{"issue":"14","key":"1523_CR22","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1177\/03331024211038884","volume":"41","author":"SL Christensen","year":"2021","unstructured":"Christensen SL, Rasmussen RH, Ernstsen C, La Cour S, David A, Chaker J et al (2021) CGRP-dependent signalling pathways involved in mouse models of GTN- cilostazol- and levcromakalim-induced migraine. Cephalalgia 41(14):1413\u20131426","journal-title":"Cephalalgia"},{"key":"1523_CR23","first-page":"55","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh T (1994) Quantitative assessment of tactile allodynia evoked by unilateral ligation of the fifth and sixth lumbar nerves in the rat. J Neurosci 53:55\u201363","journal-title":"J Neurosci"},{"key":"1523_CR24","doi-asserted-by":"crossref","unstructured":"Christensen SL, Hansen RB, Storm MA, Olesen J, Hansen TF, Ossipov M, et al (2020) Von Frey testing revisited: Provision of an online algorithm for improved accuracy of 50% thresholds. Eur J Pain 24(4):783\u2013790","DOI":"10.1002\/ejp.1528"},{"issue":"1","key":"1523_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1124\/jpet.118.253443","volume":"369","author":"CM Loomis","year":"2019","unstructured":"Loomis CM, Dutzar B, Ojala EW, Hendrix L, Karasek C, Scalley-Kim M et al (2019) Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide. J Pharmacol Exp Ther 369(1):26\u201336","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"1523_CR26","doi-asserted-by":"publisher","first-page":"e104458","DOI":"10.1371\/journal.pone.0104458","volume":"9","author":"MS Minett","year":"2014","unstructured":"Minett MS, Eijkelkamp N, Wood JN (2014) Significant determinants of mouse pain behaviour. PLoS One 9(8):e104458","journal-title":"PLoS One"},{"issue":"2","key":"1523_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3758\/BF03207805","volume":"32","author":"PJ Potvin","year":"2000","unstructured":"Potvin PJ, Schutz RW (2000) Statistical power for the two-factor repeated measures ANOVA. Behav Res Methods Instrum Comput 32(2):347\u2013356","journal-title":"Behav Res Methods Instrum Comput"},{"issue":"7","key":"1523_CR28","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1177\/0333102412441719","volume":"32","author":"J Olesen","year":"2012","unstructured":"Olesen J, Jansen-Olesen I (2012) Towards a reliable animal model of migraine. Cephalalgia 32(7):578\u2013580","journal-title":"Cephalalgia"},{"issue":"1","key":"1523_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s10194-018-0879-6","volume":"19","author":"R Greco","year":"2018","unstructured":"Greco R, Demartini C, Zanaboni AM, Tassorelli C (2018) Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing. J Headache Pain 19(1):51","journal-title":"J Headache Pain"},{"key":"1523_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejphar.2014.06.046","volume":"740","author":"A Capuano","year":"2014","unstructured":"Capuano A, Greco MC, Navarra P, Tringali G (2014) Correlation between algogenic effects of calcitonin-gene-related peptide (CGRP) and activation of trigeminal vascular system, in an in vivo experimental model of nitroglycerin-induced sensitization. Eur J Pharmacol 740:97\u2013102","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"1523_CR31","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/0333102413517776","volume":"34","author":"R Greco","year":"2014","unstructured":"Greco R, Mangione AS, Siani F, Blandini F, Vairetti M, Nappi G et al (2014) Effects of CGRP receptor antagonism in nitroglycerin-induced hyperalgesia. Cephalalgia 34(8):616\u2013623","journal-title":"Cephalalgia"},{"issue":"12","key":"1523_CR32","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1074\/mcp.RA119.001767","volume":"18","author":"KDB Anapindi","year":"2019","unstructured":"Anapindi KDB, Yang N, Romanova EV, Rubakhin SS, Tipton A, Dripps I et al (2019) PACAP and other neuropeptide targets link chronic migraine and opioid-induced hyperalgesia in mouse models. Mol Cell Proteomics 18(12):2447\u20132458","journal-title":"Mol Cell Proteomics"},{"issue":"308","key":"1523_CR33","doi-asserted-by":"publisher","first-page":"308ra157","DOI":"10.1126\/scitranslmed.aaa7557","volume":"7","author":"S Akerman","year":"2015","unstructured":"Akerman S, Goadsby PJ (2015) Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine. Sci Transl Med 7(308):308ra157","journal-title":"Sci Transl Med"},{"issue":"7","key":"1523_CR34","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1097\/j.pain.0000000000001858","volume":"161","author":"J Hoffmann","year":"2020","unstructured":"Hoffmann J, Miller S, Martins-Oliveira M, Akerman S, Supronsinchai W, Sun H et al (2020) PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache? Pain 161(7):1670\u20131681","journal-title":"Pain"},{"issue":"1","key":"1523_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/0333102420970889","volume":"41","author":"M Ashina","year":"2021","unstructured":"Ashina M, Dole\u017eil D, Bonner JH, Zhou L, Klatt J, Picard H et al (2021) A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention. Cephalalgia 41(1):33\u201344","journal-title":"Cephalalgia"},{"issue":"5","key":"1523_CR36","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1097\/j.pain.0000000000002147","volume":"162","author":"Z Guo","year":"2021","unstructured":"Guo Z, Czerpaniak K, Zhang J, Cao YQ (2021) Increase in trigeminal ganglion neurons that respond to both calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in mouse models of chronic migraine and posttraumatic headache. Pain 162(5):1483\u20131499","journal-title":"Pain"},{"issue":"6","key":"1523_CR37","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/ejn.13486","volume":"45","author":"F Farajdokht","year":"2017","unstructured":"Farajdokht F, Babri S, Karimi P, Alipour MR, Bughchechi R, Mohaddes G (2017) Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide. Eur J Neurosci 45(6):763\u2013772","journal-title":"Eur J Neurosci"},{"issue":"11","key":"1523_CR38","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1177\/0333102417748563","volume":"38","author":"F Farajdokht","year":"2018","unstructured":"Farajdokht F, Mohaddes G, Shanehbandi D, Karimi P, Babri S (2018) Ghrelin attenuated hyperalgesia induced by chronic nitroglycerin: CGRP and TRPV1 as targets for migraine management. Cephalalgia 38(11):1716\u20131730","journal-title":"Cephalalgia"},{"issue":"5","key":"1523_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.npep.2010.06.004","volume":"44","author":"K S\u00e1ndor","year":"2010","unstructured":"S\u00e1ndor K, Kormos V, Botz B, Imreh A, B\u00f6lcskei K, Gaszner B et al (2010) Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice. Neuropeptides 44(5):363\u2013371","journal-title":"Neuropeptides"},{"issue":"12","key":"1523_CR40","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2174\/1381612043384934","volume":"10","author":"D Dogrukol-Ak","year":"2004","unstructured":"Dogrukol-Ak D, Tore F, Tuncel N (2004) Passage of VIP\/PACAP\/secretin family across the blood-brain barrier: therapeutic effects. Curr Pharm Des 10(12):1325\u20131340","journal-title":"Curr Pharm Des"},{"issue":"2","key":"1523_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nurt.2010.02.003","volume":"7","author":"HW Schytz","year":"2010","unstructured":"Schytz HW, Olesen J, Ashina M (2010) The PACAP receptor: a novel target for migraine treatment. Neurotherapeutics 7(2):191\u2013196","journal-title":"Neurotherapeutics"},{"issue":"20","key":"1523_CR42","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1523\/JNEUROSCI.0439-13.2013","volume":"33","author":"C Robert","year":"2013","unstructured":"Robert C, Bourgeais L, Arreto C-D, Condes-Lara M, Noseda R, Jay T et al (2013) Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches. J Neurosci 33(20):8827\u20138840","journal-title":"J Neurosci"},{"issue":"2\u20133","key":"1523_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0014-2999(96)00359-7","volume":"311","author":"M Narita","year":"1996","unstructured":"Narita M, Dun SL, Dun NJ, Tseng LF (1996) Hyperalgesia induced by pituitary adenylate cyclase-activating polypeptide in the mouse spinal cord. Eur J Pharmacol 311(2\u20133):121\u2013126","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1523_CR44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","volume":"164","author":"A Miyata","year":"1989","unstructured":"Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L et al (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164(1):567\u2013574","journal-title":"Biochem Biophys Res Commun"},{"issue":"6442","key":"1523_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/365170a0","volume":"365","author":"D Spongier","year":"1993","unstructured":"Spongier D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburgt PH et al (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365(6442):170\u2013175","journal-title":"Nature"},{"issue":"2 Pt 2","key":"1523_CR46","first-page":"H423","volume":"270","author":"WM Armstead","year":"1996","unstructured":"Armstead WM (1996) Role of ATP-sensitive K+ channels in cGMP-mediated pial artery vasodilation. Am J Physiol 270(2 Pt 2):H423-6","journal-title":"Am J Physiol"},{"issue":"Pt 1","key":"1523_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1469-7793.1998.117bu.x","volume":"507","author":"GC Wellman","year":"1998","unstructured":"Wellman GC, Quayle JM, Standen NB (1998) ATP-sensitive K+ channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 507(Pt 1):117\u201329","journal-title":"J Physiol"},{"issue":"6","key":"1523_CR48","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1177\/0333102420975395","volume":"41","author":"NKF Wienholtz","year":"2021","unstructured":"Wienholtz NKF, Christensen CE, Zhang DG, Coskun H, Ghanizada H, Al-Karagholi MAM et al (2021) Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial. Cephalalgia 41(6):731\u2013748","journal-title":"Cephalalgia"},{"issue":"12","key":"1523_CR49","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/acn3.113","volume":"1","author":"AS Zagami","year":"2014","unstructured":"Zagami AS, Edvinsson L, Goadsby PJ (2014) Pituitary adenylate cyclase activating polypeptide and migraine. Ann Clin Transl Neurol 1(12):1036\u20131040","journal-title":"Ann Clin Transl Neurol"},{"issue":"340","key":"1523_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2016.10.046","volume":"6","author":"M Muzzi","year":"2017","unstructured":"Muzzi M, Buonvicino D, De Cesaris F, Chiarugi A (2017) Acute and chronic triptan exposure neither alters rodent cerebral blood flow nor worsens ischemic brain injury. Neuroscience 6(340):1\u20137","journal-title":"Neuroscience"},{"issue":"3","key":"1523_CR51","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pharmthera.2008.11.006","volume":"121","author":"L Dickson","year":"2009","unstructured":"Dickson L, Finlayson K (2009) VPAC and PAC receptors: From ligands to function. Pharmacol Ther 121(3):294\u2013316","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1523_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0006-8993(02)03927-6","volume":"964","author":"M Hou","year":"2003","unstructured":"Hou M, Uddman R, Tajti J, Edvinsson L (2003) Nociceptin immunoreactivity and receptor mRNA in the human trigeminal ganglion. Brain Res 964(2):179\u2013186","journal-title":"Brain Res"},{"issue":"4","key":"1523_CR53","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00001756-200203250-00030","volume":"13","author":"M Knutsson","year":"2002","unstructured":"Knutsson M, Edvinsson L (2002) Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia. NeuroReport 13(4):507\u2013509","journal-title":"NeuroReport"},{"issue":"2","key":"1523_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0333102410375624","volume":"31","author":"KY Chan","year":"2011","unstructured":"Chan KY, Baun M, De Vries R, Van Den Bogaerdt AJ, Dirven CMF, Danser AHJ et al (2011) Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia 31(2):181\u2013189","journal-title":"Cephalalgia"},{"issue":"8","key":"1523_CR55","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1468-2982.2008.01807.x","volume":"29","author":"L Boni","year":"2009","unstructured":"Boni L, Ploug K, Olesen J, Jansen-Olesen I, Gupta S (2009) The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery. Cephalalgia 29(8):837\u2013847","journal-title":"Cephalalgia"},{"issue":"3","key":"1523_CR56","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1365-2567.2007.02705.x","volume":"123","author":"M Kulka","year":"2008","unstructured":"Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP (2008) Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 123(3):398\u2013410","journal-title":"Immunology"},{"issue":"4","key":"1523_CR57","doi-asserted-by":"publisher","first-page":"540","DOI":"10.2174\/1871527314666150429114234","volume":"14","author":"J Tajti","year":"2015","unstructured":"Tajti J, Tuka B, Botz B, Helyes Z, Vecsei L (2015) Role of pituitary adenylate cyclase-activating polypeptide in nociception and migraine. CNS Neurol Disord Drug Targets 14(4):540\u2013553","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"8","key":"1523_CR58","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/00004647-200008000-00006","volume":"20","author":"J Fahrenkrug","year":"2000","unstructured":"Fahrenkrug J, Hannibal J, Tams J, Georg B (2000) Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: Relation to PACAP and VIP containing nerves. J Cereb Blood Flow Metab 20(8):1205\u20131214","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1\u20133","key":"1523_CR59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0167-0115(99)00041-5","volume":"82","author":"A Schmidt-Choudhury","year":"1999","unstructured":"Schmidt-Choudhury A, Furuta GT, Galli SJ, Schmidt WE, Wershil BK (1999) Mast cells contribute to PACAP-induced dermal oedema in mice. Regul Pept 82(1\u20133):65\u201369","journal-title":"Regul Pept"},{"issue":"1","key":"1523_CR60","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","volume":"22","author":"LH Lassen","year":"2002","unstructured":"Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22(1):54\u201361","journal-title":"Cephalalgia"},{"issue":"1","key":"1523_CR61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1468-1331.1994.tb00053.x","volume":"1","author":"LL Thomsen","year":"1994","unstructured":"Thomsen LL, Kruuse C, Iversen HK, Olesen J (1994) A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1(1):73\u201380","journal-title":"Eur J Neurol"},{"issue":"8","key":"1523_CR62","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1177\/0333102417737778","volume":"38","author":"M Ben Aissa","year":"2018","unstructured":"Ben Aissa M, Tipton AF, Bertels Z, Gandhi R, Moye LS, Novack M et al (2018) Soluble guanylyl cyclase is a critical regulator of migraine-associated pain. Cephalalgia 38(8):1471\u20131484","journal-title":"Cephalalgia"},{"issue":"1","key":"1523_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1468-1331.1996.tb00184.x","volume":"3","author":"J Brennum","year":"1996","unstructured":"Brennum J, Brinck T, Schriver L, Wanscher B, SoelbergS\u00f8rensen P, Tfelt-Hansen P et al (1996) Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache. Eur J Neurol 3(1):23\u201328","journal-title":"Eur J Neurol"},{"issue":"3","key":"1523_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WCO.0000000000000806","volume":"33","author":"D Moreno-Ajona","year":"2020","unstructured":"Moreno-Ajona D, P\u00e9rez-Rodr\u00edguez A, Goadsby PJ (2020) Gepants, calcitonin-gene-related peptide receptor antagonists. Curr Opin Neurol 33(3):1","journal-title":"Curr Opin Neurol"},{"issue":"80","key":"1523_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.vascn.2016.04.004","volume":"1","author":"SLT Christensen","year":"2016","unstructured":"Christensen SLT, Petersen S, S\u00f8rensen DB, Olesen J, Jansen-Olesen I (2016) Infusion of low dose glyceryl trinitrate has no consistent effect on burrowing behavior, running wheel activity and light sensitivity in female rats. J Pharmacol Toxicol Methods 1(80):43\u201350","journal-title":"J Pharmacol Toxicol Methods"}],"updated-by":[{"DOI":"10.1186\/s10194-023-01606-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000}}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01523-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-022-01523-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01523-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T07:01:44Z","timestamp":1686985304000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-022-01523-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1523"],"URL":"https:\/\/doi.org\/10.1186\/s10194-022-01523-8","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s10194-023-01606-0","asserted-by":"object"}]},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"2 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s10194-023-01606-0","URL":"https:\/\/doi.org\/10.1186\/s10194-023-01606-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments were conducted in accordance with ARRIVE guidelines and approved by the Danish Animal Experiments Inspectorate (ethical approval number 2017\u201315-0201\u201301,358).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0"}},{"value":"Jes Olesen owns the start-up company Cephagenics. MA is a consultant, speaker, or scientific advisor for AbbVie, Amgen, Eli Lilly, Lundbeck, Novartis, Pfizer and Teva; primary investigator for AbbVie, Amgen and Lundbeck ongoing trials. MA has no ownership interest and does not own stocks of any pharmaceutical company. MA serves as associate editor of <i>Cephalalgia<\/i>, associate editor of the <i>Journal of Headache and Pain<\/i>, and associate editor of <i>Brain<\/i>. All other authors report no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}